The Prime Minister's website has received a petition for a new law making it compulsory to microchip pets in the UK.
If you wish to support this petition, please click here and add your name: http://petitions.number10.gov.uk/MicrochipPets/
The full petition reads:
"I am a responsible pet owner and have both my parrots and dog microchipped. I genuinely believe that all pets (where possible) should be microchipped.
I feel that it should be mandatory and is part of being a responsible pet owner. This should act as a "licence". I strongly beleive that this course of action will protect many discarded, stolen and mistreated pets every year as there will be no escape for the owners as the pet can be traced back to them.
I appreciated that due to size and temperament some pets may not be able to be microchipped, but certainly dogs, cats, horses, valuable / larger birds, rabbits etc should be.
I hope you agree that £30 for a microchip is good value, if owners cannot afford this then they shouldnt be considering a pet in the first place.
Please can you give this idea serious consideration as I feel we must do something to protect the pets that do not have a voice in our society."
As part of its Pet Factor campaign, the National Office of Animal Health has launched a competition via its consumer website Pet Health Information www.pethealthinfo.org.uk to find a pet with "the Pet Factor".
NOAH is inviting owners, vets, and vet nurses to go on to the website and put forward nominations, in no more than 200 words, of animals that have staged an amazing recovery, shown exceptional bravery or set themselves apart in some other way.
The Pet Factor campaign was launched with a set of three viral videos, focussing on Pet Factor auditions for a dog, cat, and hamster that reminded owners of the importance of basic pet care.
The PHI site encourages owners to go to talk to pet care professionals to seek advice about how to keep their pets healthy and happy.
Phil Sketchley chief executive of NOAH said: "The video campaign was very successful, with over 25,000 people having watched them so far. Now we want to take the campaign further and find pets that have done something special in a way that really embodies the spirit of 'the Pet Factor'."
The winning pet and their owner will receive a full photo shoot worth over £1,000 with renowned animal photographer Sam Lunt. The final photographs will be presented to them in a beautiful bound book, to remember their special day.
If you think one of your clients deserves to win, submit your 200 word entry at www.pethealthinfo.org.uk, with a photograph if you have one. The closing date is 28 February 2010.
To improve our understanding of the attitudes of vets to treating OA pain, a survey is being conducted in seven countries across Europe (Belgium, France, Germany, Italy, Netherlands, Spain and the UK) by a group of top European veterinarians.
The Pain Expert Panel intends to publish the results for each country and also the combined European results. These publications will allow comparisons to be made between countries and types of practices.
In addition, individual vets will be able to compare their own behaviours with the findings of the survey. It is hoped that the results will highlight any areas where continuing education would be beneficial and also topics for clinical research.
The survey is web based, completely anonymous and should take no more than 20 minutes to complete. Access details are as follows:
Website: www.painsurvey.net Password: pain
There is no right or wrong answer; your opinion is the only thing that matters.
The members of the European Expert Panel on Canine Osteoarthritis are: Dr. Bernard Bouvy (Fr), Prof. Stuart Carmichael (UK), Dr. Emilio Feltri (It), Prof. Jean-Pierre Genevois (Fr), Prof. Herman Hazewinkel (NI), Prof. John Innes (UK), Prof. Martin Kramer (Ge), Prof. Duncan Laschelles (USA), Dr. Carlos Macias (Sp), Dr. Sabine Tackle (Ge), Dr. Peter Vandekerckhove (Be)
Nurtured Pets has launched the Anti-Lick Strip PreventTM, ProTM and Pro CTM, billed as an alternative to the clumsy and uncomfortable e-collar.
The Anti-Lick Strips deter animals from licking, biting or chewing of hot spots, granulomas and surgical sites. According to the company, they are also an effective deterrent to prevent such behaviours brought on by anxiety, boredom or even insect bites.
Hayley Booth, product manager at Nutured Pets said: "The UK pet market has been crying out for products like these for years. The unique bandages have medical grade adhesive on one side and all-natural active ingredients on the other. The combination of cayenne pepper, lemon powder, clove oil and oregano delivers a natural deterrent to the animal's nose and tongue to prevent it from interfering with the affected area.
"The Pro and Pro C are made exclusively for vets; the Pro can be used for direct application onto the pet's fur, ideal for securing IVs or catheters, the Pro C has a stronger adhesive and is ideal for over-wrapping gauze and cast materials.
"The Prevent then provides a profitable over the counter version for take home use. The preventative nature of these pet plasters may help promote healing and lessons the chance of infection, inflammation or re-opened wounds. In clinical trials, pets avoided the Anti-Lick Strip over 90% of the time proving these unique bandage strips really do work.
"The innovative features and benefits of the products themselves combined with extensive retail marketing support and highly visible point of sale display materials mean they're a must have for every vet practice."
For more information or a product sample, visit www.nurturedpets.co.uk or call 02476 302 222.
To celebrate the launch of its brand new keep reproduction simple advertisement campaign, CEVA Animal Health is giving British Cattle Veterinary Association (BCVA) Congress delegates the chance to win an iPod by entering a special spot the sperm competition.
BCVA Congress runs from 26-28 November 2009 in Southport. Delegates just need to spot five sperm lurking in the banner-sized cartoon for CEVA's GnRH product Ovarelin®. The correct answers will be entered into a draw to win an iPod.
The company says its new ad campaign brings together a series of cartoons with a clever play on words to highlight the importance of a simple protocol for success with reproduction. You can follow this irresistibull series in the farm media throughout the autumn.
For further information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, www.ceva.uk.com
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
Urging vets to 'get off their backsides and respond to a VMD consultation' on the introduction of a new POM-EA category (Vet Times, 19th October) is premature.
Contrary to the report, the VMD has not yet launched a formal consultation.
Jo Cawthorne from the VMD said: "In fact, we've only launched an informal consultation on a concept note amongst a small group of key stakeholders from the RCVS, BVA, RPSGB, AMTRA, AHDA and NOAH, in order to decide whether this is a viable idea and merits a formal consultation."
She added: "There is no need for vets to respond to a consultation which doesn't yet exist. If there is a formal consultation, it will be announced formally on our website and everyone will be given the opportunity to respond."
A German Shepherd bitch is making an impressive recovery from serious burns, after treatment with manuka honey impregnated dressings.
'Lady' sustained her injuries after being trapped in a blazing house in Cornwall, as reported by the BBC. She has since been under the care of Amanda Manley at the Cornwall Animal Hospital, who has been using Activon Tulle Manuka honey impregnated dressings to treat the wounds.
Amanda said: "I'd like to say it was all down to the manuka honey, although it's difficult to make a scientific judgement without a control in place. Nevertheless I am very impressed with the results and will definitely use honey again in a similar situation"
Rachel Fuller, Product Manager for Activon (medical grade manuka honey dressings) at Dechra Veterinary Products said: "In human medicine, manuka honey has become popular as a result of its antibacterial and healing properties. All honey has a degree of effectiveness, but the unique properties of manuka honey make it by far the most effective for use on wounds. It is now gaining recognition among veterinary professionals, which has led to the introduction of honey-based wound management systems for animal care".
According to Dechra, Manuka honey has been shown to be effective against over 70 strains of bacteria commonly found in wounds, including MRSA1. It also has an osmotic effect which draws fluid from a wound bed and helps to remove slough and debride necrotic tissue that can harbour bacteria and impede wound healing2. It protects the wound bed and provides a moist wound healing environment3 and the water soluble antioxidants provide favourable conditions that help to promote granulation and epithelialisation, thus faster healing. There is a rapid reduction in odour when honey is applied to a malodorous wound and it also acts as an anti-inflammatory, which therefore reduces pain.
The Cornwall Animal Hospital is a registered charity which exists to provide affordable pet care to those on a low income. It has provided all Lady's treatment at cost, including the Activon dressings, which have since been replaced by Dechra as a gesture of support.
Photographs of the case at initial examination, post debridement / pre-treatment and post treatment are in the galleries.
References
Millpledge has launched Dermafuse Tissue Adhesive, an n-butyl cyanoacrylate medical adhesive used to bond tissue together following veterinary procedures.
Dermafuse contains a blue dye to help users see where product has been applied.
On contact with body tissue, Dermafuse changes from liquid to solid state by polymerizing within seconds to seal the wound.
Millpledge says the adhesive stops minor bleeding and binds wound edges, which may eliminate the need for sutures or bandages. In some instances it also acts as a barrier to keep foreign matter from entering the wound. The tissue adhesive is sloughed as healing occurs.
Each 3g bottle contains approximately 175 drops. Four sterile applicator tips are provided with each pack.
The RCVS is seeking candidates to run for election to the RCVS and VN Councils.
There are six seats on the RCVS Council and two on the VN Council due to be filled in the 2010 election. Candidate nominations must be received by 31 January 2010; voting papers will then be distributed to all veterinary surgeons and veterinary nurses eligible to vote, the election held in March and the results announced early in May. Those elected will take their seats at RCVS Day in July to serve four-year terms.
Jane Hern, RCVS Registrar said: "Like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients. Getting regulation right is something that all Members and Listed/Registered VNs have power to influence.
"We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards," Jane continued. "There has been a substantial rise in the number of vets voting, since a low point in voter turnout was reached in 2002. So, if you know someone you think is up to the job, why not persuade them to stand?"
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, 'manifesto' and photograph for inclusion in the elections booklets. Nobody can nominate more than one candidate, and no current member of the RCVS Council or VN Council may nominate anyone.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members are permitted to claim certain expenditures arising from Council-related duties and their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk/rcvscouncil10 or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council will be online shortly at www.rcvs.org.uk/vncouncil10 and can also be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk).
All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
Protexin has announced that preliminary data from a clinical trial supports the use of Denamarin® to protect against lomustine (CCNU)-induced hepatotoxicity in dogs.
The study is being performed at the University of California-Davis, Veterinary Medical Teaching Hospital, and the initial results were recently presented at the American College of Veterinary Internal Medicine (ACVIM) Annual Forum. Marketed in the UK by Protexin, Denamarin is the combination of S-adenosylmethionine (SAMe) and silybin.
According to the company, most dogs treated with the chemotherapeutic agent CCNU experience liver enzyme elevation. Elevation of certain liver enzymes such as alanine transferase (ALT) is a key indicator of liver trauma; significant enzyme elevation may lead to a discontinuation, delay, or reduction in chemotherapy. The ongoing clinical trial was designed to evaluate Denamarin as a hepatoprotectant in dogs diagnosed with neoplasia that are undergoing CCNU therapy.
The trial consists of two groups of randomly assigned dogs. Dogs in Group 1 receive Denamarin beginning at the start of CCNU therapy. Group 2 dogs do not receive Denamarin unless they develop a Grade IV hepatotoxicity.
Results of a planned interim analysis completed on the first 30 dogs enrolled revealed that starting Denamarin when CCNU therapy was instituted (Group 1 dogs) appeared to provide hepatoprotection. While the mean post-therapy ALT elevation for Group 1 was 119 IU/L (p=0.1), for Group 2 dogs, the post-therapy ALT level was 815 IU/L (p=0.046). Chemotherapy was altered due to elevated liver enzymes in three Group 2 dogs but only one dog in Group 1.
Janine Barlow, Technical Manager at Protexin said: "We are extremely pleased by the initial findings of this research. The use of Denamarin with chemotherapy looks to help protect liver function allowing for successful completion of therapy and hopefully a longer, happier life for the pet. We look forward to the results of the full study."
Protexin says the SAMe and silybin in Denamarin support and maintain hepatic function by mechanisms including increasing levels of glutathione, the liver's main detoxifying agent; promoting protein synthesis; and stimulating bile flow. Denamarin is useful as part of a polymodal approach to the management of liver health.
Denamarin is available for both dogs and cats in an enteric-coated tablet.
A new equine parasite supplement to the online peer-reviewed publication Parasites and Vectors has been published by Fort Dodge.
Entitled "Equine parasites: diagnosis and control - a current perspective," it contains papers on a range of topics including a major European resistance study into key anthelmintic molecules. It is authored by equine parasitology experts and opinion leaders from around the world and was first published in September 2009. It is freely available at http://www.parasitesandvectors.com/
The National Office of Animal Health (NOAH) has launched a new 'Use Medicines Responsibly' campaign.
The main thrust of the campaign is an initiative by NOAH to encourage pharmaceutical companies to add: 'Use Medicines Responsibly' as a strapline to their own advertising campaigns, with a link to the NOAH information resource for prescribers and users of animal medicines: www.noah.co.uk/responsible.
Speaking at the NOAH annual members' conference in Northampton, NOAH chief executive Phil Sketchley said: "NOAH believes responsible promotion of animal medicines to be an important link in the chain towards responsible use. Companies' promotional material can educate prescribers and users of animal medicines to the benefit of their animals' health and welfare.
"We believe this new advice resource, with the reminder on advertisements, will help."
Genitrix has repackaged its Dentagen plaque prevention chews to provide added value and convenience to pet owners.
Packs of the chews, launched in 2008 as part of Genitrix' Dentagen dental range, will now be available in 'one month' packs in response to customer feedback. The new, bigger value packs will also be priced more cost-effectively and will offer environmental benefits as the amount of packaging is reduced.
Dentagen dental chews are impregnated with a plant extract called RF2 which enables them to act as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque. The chews, which come in two sizes for large and small dogs, are designed to be given on alternate days and form part of the unique Dentagen Dental Care Programme. Earlier this year, Genitrix also launched Dentagen Aqua, an innovative water additive treatment to control plaque and prevent bad breath in cats and dogs.
The new size packs of Dentagen chews, which will be available exclusively through veterinary channels, cost £6.35 for a pack of 14 small chews (one month's supply) and £8.09 for 14 large chews.
VetHelpDirect.com, a website which helps pet owners decide how urgently their pet needs veterinary attention, has been relaunched with new content for donkey, reptile and bird owners.
Founded by VetSurgeon member Susie Samuel MRCVS in 2006, the site allows pet owners to look up the symptoms their animal is displaying. When the owner answers a series of simple, step-by-step questions, the site then generates a priority rating from "Self care - treatment at home" to "Urgent - you need to contact your vet immediately", coupled with specific first aid advice. It's a sort of home triage system.
VetHelpDirect was designed by vets and all of the content is by vets. The site covers dogs, cats, rabbits, horses and now donkeys, reptiles and birds. I see that the world-renowned avian vet (and all-round good bloke) Neil Forbes FRCVS and his team at Great Western Referrals, together with Dr Karen Rickards, head vet at the Donkey Sanctuary have helped create the new areas of the website, so the information it contains will certainly be of the highest standard.
In fact, the whole site is impressively well-designed and simple to use, an opinion obviously echoed by the readers of WebUser magazine, who gave it 5/5 stars last May, beating Jamie Oliver's website.
Cleverly, the triage system on VetHelpDirect ties in with a directory of veterinary practices, so if immediate care is the answer and the owner doesn't have a vet already, help is at hand. Veterinary practices can pay to have an enhanced listing in the directory.
For a fee, VetHelpDirect can also embed the triage system into your own practice website. That seems like a good way of adding additonal, interesting and interactive content to a website. The interesting question is how much money it will save the practice by eliminating unecessary calls from pet owners who don't really need to talk to a vet.
Equally, though, the site may have an important role to play in telling owners when they SHOULD get to the vet quickly. A recent success story was that of 'Bucket', a 5 year old cat from Nottingham. Bucket was fortunate to live after his owner Sarah Rennoldson logged on to Vet Help Direct.com after he displayed odd behaviour. Acting on the advice displayed on the site her owner immediately contacted her local vet Jaqui Gilmour MRCVS at Bill Bowlers Vets. Bucket was diagnosed with a blocked bladder, which was quickly operated on. Jaqui said: ' If Sarah hadn't brought Bucket in so quickly, he could have gone into renal failure and could have developed metabolic disturbances. He would have been really, really sore, and left untreated a blocked bladder can cause death.'
For more information, 'Start a Conversation' with Susie Samuel MRCVS
The traditional NVQ 'portfolio' system for student veterinary nurses could be phased out from next summer, under draft proposals from the Royal College of Veterinary Surgeons Awarding Body, which has responsibility for the delivery of VN qualifications.
Proposals include an initial year of full-time college study, during which the student does not need to be employed in a Training Practice (TP), the introduction of compulsory farm animal work experience, the phasing out of the separate Equine Veterinary Nursing qualification and a reduction in practice-based assessment.
The catalyst for reviewing the VN qualification came from Ofqual's plans to introduce the new Qualifications and Credit Framework (QCF) from summer next year, which effectively scraps the NVQ in its current form. This gave the RCVS Awarding Body an excellent opportunity to reconsider work-based training for VNs in order to improve its effectiveness and efficiency.
The Awarding Body's proposals, on which comments are invited, aim to reduce bureaucracy for those involved with VN training, increase the number of practices able to take part and improve accessibility of training, ultimately increasing the number of qualified VNs available to the profession.
Under the new proposals, VN work-based training would be a two-year, 70-credit Level 3 qualification, equivalent to 700 hours' learning. The first year of this qualification could be delivered either as a full-time college course, or as a part-time day-release over two years (extending the complete training to three years). The first year would incorporate 25 days' work placement, including small animal, equine and farm animal environments - the first time a compulsory farm animal component has been introduced. This first year of the course could be directly accessed by school leavers, as there is no requirement for them to be employed in a practice.
Students would be employed in a Training Practice for the second 'clinical' year (or third year for part-time students). An online log of practical experience, similar to the Professional Development Phase for new veterinary graduates, would replace the current portfolio, with a more comprehensive end-of-year practical exam. There would no longer be a requirement for practice-based assessors, although students would still need to be supported by an experienced clinical mentor, a role many current assessors may assume.
The economic feasibility of Equine Veterinary Nurse (EVN) training was also considered, with the conclusion that a broader-based primary qualification, with all students carrying out work experience in a range of practice types, was more sustainable.
The number of training practices has long been recognised as a limiting factor in the UK's capacity to train VNs. In addition to standard TPs, proposals have therefore been made for Auxiliary TPs (ATPs). ATPs would be able to employ and train VN students even if they do not have the facilities to provide all of the work experience required: a formal agreement to allow students to fill the gaps at another practice would be in place.
Finally, the proposals include a beefed up range of post-registration education options, allowing Registered Veterinary Nurses to develop, and be recognised, in their own areas of interest. This would help to create a career ladder for RVNs and assist in their retention within the profession.
"The proposals have been developed following a period of consultation with those involved with the delivery of VN training, and with employers," says Jacqui Molyneux, RCVS Council Member and Chairman of the VN Awarding Body.
"Feedback suggests that the current syllabus and training provides competent nurses who are highly regarded within the profession, but that training is overly burdensome for the practices involved. This, coupled with a recognised shortage of both Training Practices and qualified VNs, meant it was appropriate to think more creatively about how the qualification could be delivered. We hope that the draft proposals will be welcomed by both the veterinary nursing and veterinary professions, and would urge people involved to let us know what they think."
The proposals are available on RCVSonline (www.rcvs.org.uk/latestnews ) - please email your comments to Miss Jane Dawson, Project Consultant (jkhdawson@aol.com), by 31 October 2009. It is appreciated that this is a short deadline, however, the time-frame of the QCF is driving development, as is the need to allow colleges and training providers the maximum possible time to develop the new training structure for 2010/11 delivery.
Equistro® has produced a dust-free pelleted presentation of Secreta Pro, following requests from clients. Secreta Pro-Max® was launched to vets at BEVA Congress.
Secreta Pro is a respiratory supplement used to support the bronchial system and natural defences on a long term basis.
For more information on Secreta Pro-Max® and all Equistro products, please visit http://www.equistro.co.uk/, or contact your Vetoquinol representative.
To mark its 20th anniversary, Woodley Equipment Company is holding a prize draw to win one of three bottles of Chateau Pitray 1989 Bordeaux red wine.
Woodley Equipment Company Ltd was established in 1989 by Mike Wickham, a biomedical scientist who specialises in haematology and blood transfusion.
Visit www.woodley20years.com to enter the draw. The winner will be drawn on Friday 30th October 2009.
Two days left in which to enter Vetoquinol's competition to win up to £300 worth of CPD or a goody bag.
To enter, answer the 7 multi-choice questions here.
Britain's dairy industry is doomed unless it takes more effective steps to control the spread of endemic diseases like tuberculosis and bovine virus diarrhoea, according to a leading cattle vet.
At a conference on infectious disease at the Royal Veterinary College last week, Devon practitioner Dick Sibley warned that the management and economic trends in the UK dairy industry are increasing the risk of disease transmission - and its potential impact once it does enter a herd.
Figures he obtained from the British Cattle Movements Service show that about four million cattle, or half the total UK cattle herd, are moved from one premises to another each year. Those being sent for slaughter were unlikely to spread infections but moving cattle of unknown disease status to new premises greatly increased the risk of bringing in new diseases. "If you set out to design a system that guarantees that we will continue to have problems with endemic disease then I could not think of a better one than this," he said.
Cattle numbers are increasing in those areas like Devon and Cheshire which already have among the highest population densities for dairy animals in the world - and are also the main hot spots in the current bovine TB epidemic. Farmers feel compelled to buy in heifers from as far afield as Germany and Holland to replace animals culled as TB reactors, as they will lose bonus payments from customers who demand that they maintain constant levels of production.
Several other factors also increase the likely impact of disease in a previously healthy herd - the concentration of cattle numbers into fewer but larger units, the growing emphasis on cattle kept indoors all year round and breeding for high yielding animals that are more vulnerable to disease. Meanwhile, a shortage of skilled manpower means that half the available stockmen are shared between farms and can therefore be responsible for bringing in disease.
But farmers have little or no control over some of the more important risk factors - particularly movements of badgers and the presence of diseased herds on neighbouring premises. "So these farmers with big herds in high density areas and neighbours that have the disease are done for unless we can do something serious to manage the risks."
Dairy farmers can work with their veterinary advisers to reduce risk using the four main pillars of disease control - improved biosecurity, better surveillance, appropriate vaccination and containment of disease transmission within the herd. But diseases also had to be tackled on a national level and if DEFRA is unwilling to take on the task, he proposed the creation of an independent livestock disease agency with sufficient staff and resources to carry out its remit. The costs of running such a body should be shared among all those stakeholders with an interest in preserving an economically viable dairy industry, including, for example the cereal producers who provide the dairy industry with much of its food materials, he suggested.
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
Boehringer Ingelheim Vetmedica has launched a unique and natural muscle building supplement for horses, Equitop Myoplast Power Pearls, containing 18 key amino acids.
The company says maintaining muscular condition in performance and sports horses can be challenging, especially when work load is increased or during periods of convalescence, as feeding high levels of concentrates can often lead to horses becoming 'fizzy' and bulking up on fats and oils.
Scientifically designed to support lean muscle growth, not bulk, Equitop Myoplast Power Pearls is great for optimising performance in horses in intensive training and competition, as well as bringing on young, breeding and injured animals, and for older horses which lose condition easily.
The product is endorsed by top British show jumper, Ellen Whitaker and veterinary surgeon and dressage rider, Christel Robbins BVSc MRCVS.
Craig Beck from Boehringer Ingelheim Vetmedica said: "Equitop Myoplast Power Pearls is already one of the most popular equine supplements sold in Germany and is used by top riders in all disciplines to help ensure their horses reach their full athletic potential. We are certain that with the support of riders such as Ellen Whitaker, Equitop Myoplast Power Pearls will prove just as popular in the UK."
Equitop Myoplast Power Pearls is available in a 1.5kg tub (RRP £65) and can be fed separately or mixed with feed. Horses weighing less than 500kg should be fed one scoop (25g) per day, while larger horses should receive two scoops (50g). Boehringer Ingelheim Vetmedica recommends that Equitop Myoplast Power Pearls is fed for at least a month as results are normally visible within 3-4 weeks.
Boehringer Ingelheim Vetmedica is committed to supporting veterinary practices and Equitop Myoplast Power Pearls will be distributed exclusively by veterinary wholesalers. An extensive advertising campaign in professional equine publications will help raise awareness of Equitop Myoplast Power Pearls and, for a limited period, horse owners and equine professionals can download a voucher from http://www.equitop-myoplast.co.uk/ offering a £15 rebate against their first purchase. Veterinary practices can redeem these vouchers by returning them to Boehringer Ingelheim Vetmedica via a freepost address.
For further information on Equitop Myoplast Power Pearls, please contact your local Boehringer Ingelheim Vetmedica representative, visit www.equitop-myoplast.co.uk or call 01344 746959.
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
Following a two-year postponed judgment, the Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week warned a Cambridgeshire veterinary surgeon as to his future conduct, after he had been convicted in 2006 for causing death by careless driving whilst under the influence of alcohol.
In September 2007, the Committee heard that Peter Hanlon MRCVS, of Soham in Cambridgeshire, had been involved in a road traffic accident in February 2006. Mr Hanlon's car had drifted across the road and collided with an oncoming car driven by James Barber who was accompanied by his wife, Ivy. Mr Barber was pronounced dead at the scene and both Mrs Barber and Mr Hanlon sustained injuries.
At the initial hearing, Mr Hanlon admitted the conviction (for which he had been sentenced to 30 months in prison and received a four-year driving ban) and the charge that it rendered him unfit to practise veterinary surgery. The Committee decided to postpone its judgment for two years on the agreement that Mr Hanlon would undertake to abstain from alcohol and to submit quarterly medical reports and six-monthly CPD (continuing professional development) reports to the Committee chairman.
At the resumed hearing last week, the Committee carefully considered Mr Hanlon's written and oral submissions, and accepted that he had fully complied with these undertakings. He had abstained from alcohol since the day after the accident, produced an "exemplary" CPD record and provided impressive reports from his employers concerning his professional competence.
In addition, Mr Hanlon, who spent around 14 months in prison and remained on licence until July 2009, also reiterated to the Committee his remorse for the death of Mr Barber and respect for his family.
The Committee was mindful of its duty to maintain confidence in the veterinary profession and uphold proper standards of conduct. Whilst it did not consider it necessary to postpone judgment again, it felt that Mr Hanlon should be warned about his future conduct.
Caroline Freedman, chairing the Committee, concluded: "As this case has demonstrated, and as Mr Hanlon himself has fully recognised, abuse of alcohol can lead to far reaching consequences in personal and professional lives and the lives of others."
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new website with up-to-date advice and guidance on the subject of equine pain management for horse owners: http://www.equinepainmatters.com/
Dechra says the website offers owners a place to go for information about pain in their horse including causes, diagnosis and the tools and techniques that their vet may use to treat pain. Owners will also be able to download anatomy charts and information leaflets on topics such as pain management, lameness, anaesthesia, sedation, euthanasia, the importance of microchipping and wound management.
Larry King, equine product manager at Dechra said: "This website is great for horse owners as they now have one place to go for information about equine pain matters. It will help them gain a better understanding of managing pain in their horses and the critical role that their vet plays in this area. Veterinary practices can also refer owners to it to support their consultation. This is the first website to put all this information together, so we are sure it will be popular.
"Cards with the new website address are available for practices to hand out to clients. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials."
Dechra also encourages practices that have their own websites to link directly to www.equinepainmatters.com. Practices can order hand-out cards by contacting Dechra on 01743 441632 or email marketing@dechra.com.